MARATTO

letter · Psychiatry and Clinical Neurosciences

Response to [Comment on is clozapine use a risk of hematological malignancies? Insights from a meta‐analysis “Clozapine and Malignancy Risk”]

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

This article relates to Comment on: is clozapine use a risk of hematological malignancies? Insights from a meta‐analysis “Clozapine and Malignancy Risk”.

Research topics

  • Schizophrenia research and treatment
  • Electroconvulsive Therapy Studies
  • Mental Health and Psychiatry

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1111/pcn.13856

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.